RxDoctor Payments Data

Melissa Sealy

Family · Lafayette, LANPI 1811391865

Payments from drug & device makers

$7,318in general payments, 2019–2025

Across 460 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AstraZeneca$1K
  • AbbVie$939
  • Lilly USA, LLC$674
  • Takeda Pharmaceuticals U.S.A., Inc.$354
  • Corium, LLC$279
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$7,318100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,318 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$32,350
MounjaroTirzepatide31$31,763
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$18,015
MovantikNaloxegol Oxalate13$4,461
Aripiprazole19$3,741
SynthroidLevothyroxine Sodium29$2,106
Bupropion XlBupropion Hcl36$1,399
Duloxetine Hcl34$1,312
Pantoprazole Sodium81$870
Amlodipine Besylate119$848
Nabumetone62$805
Levothyroxine Sodium73$795
Albuterol Sulfate HfaAlbuterol Sulfate27$757
Esomeprazole Magnesium14$719
Fluticasone Propionate35$620

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$61$32,35037 claims
Lilly USA, LLCMounjaro$674$31,76331 claims
GSKTrelegy Ellipta$1,241$18,01527 claims
AbbVieSynthroid$939$2,10629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,610 family providers in Louisiana.

Other family in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →